MedPath

Investigating the effect of dexamethasone injection in the first 24 hours in preventing kidney scaring in children with pyelonephritis

Phase 3
Recruiting
Conditions
Acute pyelonephritis.
Vesicoureteral-reflux
N13.7
Registration Number
IRCT20231226060526N1
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Children from 1 month to 12 years with first episode of fever T > 38°C
having a urinary tract infection and a positive urine culture
The presence of a positive urine culture, which according to the definition includes at least 100000 CFUs/mL from a clean sample obtained with a urine bag, or at least 10000 CFUs/mL from a sample obtained by catheterization, or the growth of any amount of bacteria from a sample obtained by suprapubic aspiration.

Exclusion Criteria

Endocrine disease
Immunosuppressive therapy
Known cancer or uropathy
Those who had an abnormal DMSA before late assessment (at least 6 months follow-up) had a second UTI.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome of presence of renal scar in Dimercaptosuccinic acid renal scan. Timepoint: 6-month follow-up. Method of measurement: Dimercaptosuccinic acid (DMSA) renal scan.
Secondary Outcome Measures
NameTimeMethod
The presence of kidney scar in children groups A and B with higher Procalcitonin and the acceptability of steroid adjuvant in terms of the amount of treatment and side effects. Timepoint: 6-month follow-up. Method of measurement: Dimercaptosuccinic acid (DMSA) renal scan.
© Copyright 2025. All Rights Reserved by MedPath